Lecap Asset Management Ltd. Increases Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Lecap Asset Management Ltd. boosted its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 33.1% during the 4th quarter, HoldingsChannel.com reports. The fund owned 11,955 shares of the medical device company’s stock after buying an additional 2,974 shares during the period. Lecap Asset Management Ltd.’s holdings in Cooper Companies were worth $1,099,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in COO. Ashton Thomas Securities LLC bought a new position in shares of Cooper Companies during the third quarter valued at $25,000. Covestor Ltd raised its position in Cooper Companies by 144.9% in the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after buying an additional 200 shares during the last quarter. Brown Brothers Harriman & Co. lifted its stake in Cooper Companies by 191.0% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock valued at $46,000 after acquiring an additional 275 shares during the period. West Financial Advisors LLC purchased a new stake in shares of Cooper Companies during the 4th quarter valued at about $49,000. Finally, Friedenthal Financial bought a new stake in shares of Cooper Companies in the third quarter worth approximately $50,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the stock. StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Wells Fargo & Company increased their price target on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, December 6th. Morgan Stanley cut their price objective on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. Finally, Citigroup cut their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Cooper Companies presently has an average rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Trading Down 1.8 %

Cooper Companies stock opened at $93.57 on Friday. The Cooper Companies, Inc. has a 12-month low of $84.76 and a 12-month high of $112.38. The firm has a market capitalization of $18.67 billion, a price-to-earnings ratio of 47.98, a P/E/G ratio of 2.45 and a beta of 1.00. The firm has a 50 day moving average of $94.99 and a 200 day moving average of $99.73. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Thursday, December 5th. The medical device company reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. During the same period in the prior year, the company posted $0.87 earnings per share. The company’s revenue for the quarter was up 9.8% compared to the same quarter last year. As a group, research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.